TY - JOUR
T1 - Improved survival of pediatric deceased donor liver transplantation recipients after introduction of the pediatric prioritization system
T2 - Analysis of data from a Japanese national survey
AU - the Japanese Liver Transplantation Society
AU - Takemura, Yusuke
AU - Shinoda, Masahiro
AU - Kasahara, Mureo
AU - Sakamoto, Seisuke
AU - Hatano, Etsuro
AU - Okamoto, Tatsuya
AU - Ogura, Yasuhiro
AU - Sanada, Yukihiro
AU - Matsuura, Toshiharu
AU - Ueno, Takehisa
AU - Obara, Hideaki
AU - Soejima, Yuji
AU - Umeshita, Koji
AU - Eguchi, Susumu
AU - Kitagawa, Yuko
AU - Egawa, Hiroto
AU - Ohdan, Hideki
AU - Ogawa, Eri
AU - Ito, Takashi
AU - Sakuma, Yasunaru
AU - Yoshizumi, Tomoharu
AU - Eguchi, Hidetoshi
AU - Shimamura, Tsuyoshi
AU - Mita, Atsuyoshi
AU - Hibi, Taizo
AU - Fukumoto, Takumi
AU - Hasegawa, Kiyoshi
AU - Marubashi, Shigeru
AU - Umeda, Yuzo
AU - Nobori, Shuji
AU - Hasegawa, Yasushi
AU - Yamada, Yohei
AU - Kitago, Minoru
N1 - Publisher Copyright:
© 2024 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
PY - 2024/11
Y1 - 2024/11
N2 - Background: In Japan, there has never been a national analysis of pediatric deceased donor liver transplantation (pDDLT) based on donor and recipient factors. We constructed a Japanese nationwide database and assessed outcomes of pDDLT focusing on the pediatric prioritization system introduced in 2018. Methods: We collected data on pDDLTs (<18 years) performed between 1999 and 2021 from the Japan Organ Transplant Network and Japanese Liver Transplantation Society, identified risk factors for graft survival and compared the characteristics and graft survival in pDDLTs conducted before and after the introduction of the pediatric prioritization system. Results: Overall, 112 cases of pDDLT were included, with a 1-year graft survival rate of 86.6%. Four poor prognostic factors were identified: recipient intensive care unit stay, model for end-stage liver disease/pediatric end-stage liver disease score, donor cause of death, and donor total bilirubin. After the introduction of the system, allografts from pediatric donors were more reliably allocated to pediatric recipients and the annual number of pDDLTs increased. The 1-year graft survival rate improved significantly as did pDDLT conditions indicated by the risk factors. Conclusions: Under the revised allocation system, opportunities for pDDLT increased, resulting in favorable recipient and donor conditions and improved survival.
AB - Background: In Japan, there has never been a national analysis of pediatric deceased donor liver transplantation (pDDLT) based on donor and recipient factors. We constructed a Japanese nationwide database and assessed outcomes of pDDLT focusing on the pediatric prioritization system introduced in 2018. Methods: We collected data on pDDLTs (<18 years) performed between 1999 and 2021 from the Japan Organ Transplant Network and Japanese Liver Transplantation Society, identified risk factors for graft survival and compared the characteristics and graft survival in pDDLTs conducted before and after the introduction of the pediatric prioritization system. Results: Overall, 112 cases of pDDLT were included, with a 1-year graft survival rate of 86.6%. Four poor prognostic factors were identified: recipient intensive care unit stay, model for end-stage liver disease/pediatric end-stage liver disease score, donor cause of death, and donor total bilirubin. After the introduction of the system, allografts from pediatric donors were more reliably allocated to pediatric recipients and the annual number of pDDLTs increased. The 1-year graft survival rate improved significantly as did pDDLT conditions indicated by the risk factors. Conclusions: Under the revised allocation system, opportunities for pDDLT increased, resulting in favorable recipient and donor conditions and improved survival.
KW - brain death
KW - cohort studies
KW - graft survival
KW - liver transplantation
KW - pediatrics
UR - http://www.scopus.com/inward/record.url?scp=85201805139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85201805139&partnerID=8YFLogxK
U2 - 10.1002/jhbp.12062
DO - 10.1002/jhbp.12062
M3 - Article
C2 - 39160627
AN - SCOPUS:85201805139
SN - 1868-6974
VL - 31
SP - 782
EP - 797
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
IS - 11
ER -